Medicine and Dentistry
Kidney Graft
100%
Kidney Transplantation
73%
Graft Failure
34%
Transplantation
30%
Kidney Function
22%
Quality of Life
21%
Cohort Analysis
18%
Glomerular Filtration Rate
15%
Graft Survival
14%
COVID-19
14%
Urinary System
13%
Immunosuppressive Treatment
13%
Complement Activation
12%
Hazard Ratio
12%
Delayed Graft Function
10%
Prospective Cohort Study
9%
Nephropathy
9%
Cardiovascular System
8%
Everolimus
8%
Creatinine
8%
Biopsy
8%
Calcineurin Inhibitor
7%
Ischemia
7%
Proportional Hazards Model
6%
Tacrolimus
6%
Lupus Nephritis
6%
Mannose Binding Lectin
6%
Atypical Hemolytic Uremic Syndrome
6%
Brain Death
6%
Outpatient
6%
Recurrent Disease
6%
Proteinuria
6%
Randomized Controlled Trial
6%
Kidney Allograft
5%
Biological Marker
5%
Mycophenolic Acid
5%
All Cause Mortality
5%
Eculizumab
5%
Acute Kidney Injury
5%
Infection
5%
Keyphrases
Kidney Transplant Recipients
64%
Kidney Transplantation
30%
Health-related Quality of Life
20%
Renal Transplant Recipients
19%
Transplantation
17%
Biobank
16%
Prospective Cohort Study
13%
Graft Failure
12%
Pretransplant
12%
Kidney Function
10%
Complement Activation
10%
Estimated Glomerular Filtration Rate
10%
Living Kidney Donor
9%
Confidence Interval
9%
Kidney
9%
Iron Deficiency
8%
Proton Pump Inhibitors
7%
Mannose-binding Lectin
7%
Graft Survival
6%
Proteinuria
6%
Pre-donation
6%
Hazard Ratio
6%
Cardiovascular Mortality
5%
Delayed Graft Function
5%
Egfr
5%
Immunology and Microbiology
Transplant Procedure
65%
Kidney Transplantation
37%
Complement Activation
24%
Properdin
13%
Tacrolimus
11%
Mannose Binding Lectin
10%
Blood Plasma
9%
Glomerulus Filtration
8%
Kidney Function
8%
Nephritis
8%
Lupus Erythematosus
8%
Complement System
7%
Lectin Pathway
6%
Systemic Lupus Erythematosus
6%
Allotransplantation
6%
Pancreas
5%
Solid Organ Transplantation
5%
Monospecific Antibody
5%
Perfusion
5%
C3b
5%
